ASPISAFE NG + 

2022

ASPISAFE NG + 

Stomach reflux is independently associated with problems including aspiration pneumonia, acute respiratory distress syndrome and gastrointestinal bleeding, especially in patients in the intensive care unit. This leads to higher hospital costs and worse patient outcomes. 

Animal Study

Preliminary Animal studies showed significant reflux prevention using the Aspisafe tube compared to the normal feeding tube. The study demonstrated no safety concerns with the esophageal balloon. Severe esophageal erosions is the leading cause of gastrointestinal bleeding in ICU patients and is very much correlated with reflux. 

aspisafeng+ tube inflated_edited.jpg

Fig. 1

ASPISAFE NG+ inflated balloon

control device esophagus_edited.jpg

Standard NG Tube

Fig. 2

aspisafeng+ deflated balloon_edited.jpg

Fig. 3

ASPISAFE NG+ deflated balloon

aspisafeng+ deflated balloon_edited.jpg

Standard NG Tube

Fig. 4

Fig 1-4 showing severe esophagitis and inflammation on the right vs. a clean esophagus on the left on day 2 from animal testing.  Fig 2 & 4 showing severe erosions and inflammation in esophagus using a standard feeding tube.